TYK Medicines FY26 H1 comprehensive loss narrows 76.4% to RMB 26.88 millionPUBT·Aug 17 at 07:34 AM02410+1.78%
TYK Medicines files list of directors, board committee memberships and disclosure-responsible managementPUBT·Aug 17 at 07:15 AM02410+1.78%
TYK Medicines non-executive director Jiang Mingyu resigns, Wu Yusheng named authorized representativePUBT·Aug 17 at 07:05 AM02410+1.78%
TYK Medicines schedules board meeting to review interim results, consider dividendPUBT·Aug 5 at 04:16 AM02410+1.78%
TYK Medicines sues Huiyu Pharma over disputed TY-9591 cooperation dealPUBT·Jul 22 at 09:52 AM02410+1.78%688553+0.33%
TYK Medicines prices private placement of 63,222,744 H shares at HK$ 7.3 eachPUBT·Jul 21 at 06:22 AM02410+1.78%
TYK Medicines shareholders pass Articles of Association amendments at AGMPUBT·Jun 23 at 05:44 AM02410+1.78%
